questionText: To ask the Secretary of State for Defence, if he will ensure that the MOD Defence Medical Service updates its policy on Mefloquine-damaged veterans to (a) acknowledge the recent confirmation by NHS England that Mefloquine neurotoxicity (i) exists and (ii) requires clinical management, (b) accept that misdiagnosis of Mefloquine-damaged veterans as having PTSD can lead to the prescribing of inappropriate psychiatric medication (A) leading to serious worsening of their condition and (B) impeding the search for effective treatment of brain damage caused by Mefloquine, and (c) develop a communications strategy, in conjunction with other relevant MOD bodies and the NHS, to make veterans and GPs aware that veterans presenting with suicidal ideation should routinely be checked for exposure to Mefloquine during their past service in the armed forces.
answerText: I refer the hon. member to the answer provided by the Department of Health and Social Care (DHSC) in January this year. https://questions-statements.parliament.uk/written-questions/detail/2026-01-12/104605 The Ministry of Defence (MOD) and DHSC recognise ...
heading: Veterans: Mefloquine